A GLOBAL, RANDOMIZED, DOUBLE-BLINDED, PHASE 3 STUDY OF VORASIDENIB VERSUS PLACEBO IN PATIENTS WITH ADULT-TYPE DIFFUSE GLIOMA WITH AN IDH1/2 MUTATION (INDIGO): UPDATED EFFICACY RESULTS Ingo K. Mellinghoff , Martin J. van den Bent , Mehdi Touat , Deborah T. Blumenthal , Katherine B. Peters , Benjamin M. Ellingson , Jennifer L. Clarke , Joe Mendez , Shlomit Yust-Katz , Warren P. Mason , Francois Ducray , Yoshie Umemura , Burt Nabors , Andreas F. Hottinger , Yoshiki Arakawa , Juan M. Sepulveda , Wolfgang Wick , Riccardo Soffietti , James R. Perry , Pierre Giglio , Macarena de la Fuente , Elizabeth A. Maher , Adriana E. Tron , Dan Zhao , Shuchi S. Pandya , Lori Steelman , Islam Hassan , Patrick Y. Wen , Timothy F. Cloughesy NEURO-ONCOLOGY（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
